1. Immunological Profile and Predisposition to Autoimmunity in Girls With Turner Syndrome
- Author
-
Elżbieta Berdej-Szczot, Ewa Błaszczyk, Ewa Małecka-Tendera, Magdalena Hankus, Aneta Gawlik, Renata Klekotka, Dorota Blat, and Tomasz Gawlik
- Subjects
0301 basic medicine ,Cellular immunity ,Regulatory T cell ,Turner syndrome ,T regulatory cells ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,medicine.disease_cause ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,Autoimmunity ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,IL-2 receptor ,lcsh:RC648-665 ,biology ,business.industry ,autoimmunity ,Autoantibody ,lymphocytes subpopulation ,medicine.disease ,030104 developmental biology ,medicine.anatomical_structure ,Immunology ,biology.protein ,Antibody ,business ,CD8 - Abstract
ObjectiveThe risk of autoimmune diseases (AD) in patients with Turner Syndrome (TS) is twice higher than in the general female population and four times higher than in the male population. The causes of the increased incidence of AD in TS are still under discussion. We hypothesized the presence of a specific humoral, cellular, and regulatory T cell (Treg) immunity profile which predisposes to AD, disorders of immunity, and disorders of immune regulation.MethodsThe study encompassed 37 girls with TS and with no signs of infection. The control group included 11 healthy girls with no hormonal disorders. A medical history focused on AD and immunity disorders was taken from all participants. The levels of: immunoglobulins IgG, IgA, IgM, total lymphocytes, lymphocytes subpopulations CD3+, CD4+, CD8+, CD19+, natural killer cells, Treg cells (CD4+ CD25+ CD127− FOXP3+), anti-inflammatory cytokines (interleukin-10, transforming growth factor-β), anti-nuclear antibodies, glutamic acid decarboxylase (GAD65 Abs), anti-thyroid peroxidase (anti-TPO Ab), and anti-thyroglobulin (anti-TG Ab) autoantibodies were determined in each participant.ResultsThe mean age and BMI in the TS group and in controls were comparable (11.9 ± 4.1 vs. 12.5 ± 4.0 years; 19.2 ± 3.4 vs. 19.7 ± 4.6, p > 0.05). Mean hSDS was significantly higher in controls (−2.2 ± 0.9 vs. −0.4 ± 1.5, p
- Published
- 2018